Washington State insurers impose double digit rate hikes, again

08/03/09
"In what is becoming an annual ordeal for policyholders, Regence BlueShield is raising premiums for 135,000 individual health-plan members in Washington [state] by an average 17 percent on Aug. 1," the Seattle Times reports.

The insurer's president attributed the rate hikes to "higher medical claims, inflation, costly prescription drugs and the expenses of treating a population that is aging and growing less healthy." Other Washington insurers have also hiked rates in recent months, and it's the third straight year that Regence policy holders have had double-digit increases. Group Health Cooperative, a co-op which is owned by its policyholders, much like the organizations that would be created to compete with private insurers in hopes of reducing medical spending under one Senate reform proposal, raised its rates by 13 percent in June. Another insurer, LifeWise, hiked its own by 17.6 that month. Insurers "get away with rate increases in this market because they can," Kathleen O'Connor a Regence customer and reform activist told the Times. "I'm not sure why the insurance commissioner is not all over these rate increases." Others told the Times that they believed a government-run health insurance plan, another reform proposal, would force the companies to change their policies. Conservatives say such a plan could drive insurers out of business. But "that only goes to prove the point," said a Washington resident and Regence customer, who thinks it might not be a bad idea to drive some private insurers out of business (Song, 7/9). This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Source: http://www.kaisernetwork.org (Author: 9. July 2009 18:56)

Best Sellers
  1. Sildenafil
  2. Vardenafil
  3. Tadalafil
  4. Xenical
  5. Zyrtec
  6. Valtrex
  7. Tamiflu
  8. Lipitor
Recent News
02/16/10
Celebrex and Lipitor against prostate cancer
Two widely used drugs - cholesterol-lowering (Lipitor) and anti-inflammatory (Celebrex ) - may be effective in the treatment of prostate cancer.
read more ...
02/03/10
Allegra Antihistamine drug of the third millennium
In 1996, the U.S. market saw the launch of the first representative of the third-generation antihistamines named Allegra (fexofenadine), which is the original drug of Aventis Pharma. In 2000, sales of Allegra amounted to 1.166 billion Euro around the worl
read more ...
02/03/10
Amoxicillin, the drug of first choice in infectious and inflammatory diseases in children
Published results of a randomized international study involving 1,702 patients aged 3-59 months with severe pneumonia showed that treatment regimens with the use of parenteral penicillin and oral doses of amoxicillin did not differ in effectiveness.
read more ...